Amino-terminally truncated Aβ peptide species are the main component of cotton wool plaques

Biochemistry

Volumn 44, Issue 32, 2005, Pages 10810-10821

  Miravalle, Leticia ^a   Calero, Miguel ^b   Takao, Masaki ^a   Roher, Alex E ^c   Ghetti, Bernardino ^a   Vidal, Ruben ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BRAIN; CHARACTERIZATION; DEPOSITION; DIAGNOSIS; DISEASES; GENES; IONIZATION; MASS SPECTROMETRY;

ALZHEIMER DISEASE; COTTON WOOL PLAQUES (CWP); LASER DESORPTION IONIZATION; PEPTIDES;

AMINO ACIDS;

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[1-43]; PRESENILIN 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN; BRAIN CORTEX; CEREBELLUM CORTEX; CONTROLLED STUDY; COTTON WOOL PLAQUE; DIAGNOSTIC TEST; GENE MUTATION; HUMAN; HUMAN TISSUE; LEPTOMENINX; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MISSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AUTOPSY; BLOOD VESSELS; CEREBRAL CORTEX; FAMILY HEALTH; HUMANS; MEMBRANE PROTEINS; MUTATION, MISSENSE; PEPTIDE FRAGMENTS; PRESENILIN-1; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

GOSSYPIUM HIRSUTUM;

EID: 23844551164     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0508237     Document Type: Article

References (48)

1. Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev. 81, 741-766.
2. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science 286, 735-741.
3. Gu, Y., Sanjo, N., Chen, F., Hasegawa, H., Petit, A., Ruan, X., Li, W., Shier, C., Kawarai, T., Schmitt-Ulms, G., Westaway, D., St. George-Hyslop, P., and Fraser, P. E. (2004) The presenilin proteins are components of multiple membrane-bound complexes that have different biological activities, J. Biol. Chem. 279. 31329-31336.
4. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci. 13, 1676-1687.
5. Younkin, S. G. (1995) Evidence that Aβ 42 is the real culprit in Alzheimer's disease, Ann. Neurol. 37, 287-288.
6. Klein, W. L. (2002) Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets, Neurochem. Int. 41, 345-352.
7. Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053.
8. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249.
9. Mori, H., Takio, K., Ogawara, M., and Selkoe, D. J. (1992) Mass spectrometry of purified amyloid beta protein in Alzheimer's disease, J. Biol. Chem. 267, 17082-17086.
10. Miller, D. L., Papayannopoulos, I. A., Styles, J., Bobin, S. A., Lin, Y. Y., Biemann, K., and Iqbal, K. (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease, Arch. Biochem. Biophys. 301. 41-52.
11. Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zurcher-Neely, H. A., Heinrikson, R. L., Ball, M. J., and Greenberg, B. D. (1993) Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease, J. Biol. Chem. 268, 3072-3083.
12. Kuo, Y. M., Emmerling, M. R., Woods, A. S., Cotter, R. J., and Roher, A. E. (1997) Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits, Biochem. Biophys. Res. Commun. 237, 188-191.
13. Naslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., Silberring, J., Gandy, S. E., Winblad, B., Greengard, P., Nordstedt, C., and Terenius, L. (1994) Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging, Proc. Natl. Acad. Sci. U.S.A. 91, 8378-8382.
14. Tekirian, T. L. (2001) Abeta N-Terminal Isoforms: Critical contributors in the course of AD pathophysiology. J. Alzheimer's Dis. 3, 241-248.
15. Russo, C., Schettini, G., Saido, T. C., Hulette, C., Lippa, C., Lannfelt, L., Ghetti, B., Gambetti, P., Tabaton, M., and Teller, J. K. (2000) Presenilin-1 mutations in Alzheimer's disease, Nature 405, 531-532.
16. Saido, T. C., Iwatsubo, T., Mann, D. M., Shimada, H., Ihara, Y., and Kawashima, S. (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques, Neuron 14, 457-466.
17. Iwatsubo, T., Saido, T. C., Mann, D. M., Lee, V. M., and Trojanowski, J. Q. (1996) Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42-(43) deposit in diffuse plaques, Am. J. Pathol. 149, 1823-1830.
18. Gouras, G. K., Xu, H., Jovanovic, J. N., Buxbaum, J. D., Wang, R., Greengard, P., Relkin, N. R., and Gandy, S. (1998) Generation and regulation of beta-amyloid peptide variants by neurons, J. Neurochem. 71, 1920-1925.
19. Gowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P., and Ball, M. J. (1994) Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease, J. Biol. Chem. 269, 10987-10990.
20. Higgins, L. S., Murphy, G. M., Jr., Forno, L. S., Catalano, R., and Cordell, B. (1996) P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain, Am. J. Pathol. 149, 585-596.
21. Prelli, F., Castaño, E. M., Glenner, G. G., and Frangione, B. (1988) Differences between vascular and plaque core amyloid in Alzheimer's disease, J. Neurochem. 51, 648-651.
22. Vidal, R., Calero, M., Piccardo, P., Farlow, M. R., Unverzagt, F. W., Mendez, E., Jimenez-Huete, A., Beavis, R., Gallo, G., Gomez-Tortosa, E., Ghiso, J., Hyman, B. T., Frangione, B., and Ghetti, B. (2000) Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele, Acta. Neuropathol. (Berlin) 100, 1-12.
23. Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M., Tan, H., Games, D., Lieberburg, I., Schenk, D., Seubert, P., and McConlogue, L. (1997) Amyloid precursor protein processing and A beta 42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94, 1550-1555.
24. Frenkel, D., Balass, M., and Solomon, B. (1998) N-terminal EFRH sequence of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies, J. Neuroimmunol. 88, 85-90.
25. Jimenez-Huete, A., Alfonso, P., Soto, C., Albar, J. P., Rabano, A., Ghiso, J., Frangione, B., and Mendez, E. (1998) Antibodies directed to the carboxyl terminus of amyloid β-peptide recognize sequence epitopes and distinct immunoreactive deposits in Alzheimer's disease brain, Alzheimer Rep. 1, 41-48.
26. Takao, M., Ghetti, B., Hayakawa, I., Ikeda, E., Fukuuchi, Y., Miravalle, L., Piccardo, P., Murrell, J. R., Glazier, B. S., and Koto, A. (2002) A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum, Acta Neuropathol (Berlin) 104, 155-170.
27. Sehested, M., and Hou-Jensen, K. (1981) Factor VII related antigen as an endothelial cell marker in benign and malignant diseases, Virchows Arch. A: Pathol. Anat. Histol. 391, 217-225.
28. Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., and Gabbiani, G. (1986) A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation, J. Cell Biol. 103, 2787-2796.
29. Shi, S. R., Cote, R. J., and Taylor, C. R. (1997) Antigen retrieval immunohistochemistry: past, present, and future, J. Histochem. Cytochem. 45, 327-343.
30. Farlow, M., Murrell, J. R., Unverzagt, F. W., Phillips, M., Takao, M., and Ghetti, B. (2001) Familial Alzheimer's disease with spastic paraparesis associated with a mutation at codon 261 of the presenilin 1 gene, in Alzheimer's disease: advances in etiology, pathogenesis and therapeutics (Iqbal, K., Sisodia, S. S., and Winblad, B., Eds), pp 53-60, John Wiley & Sons, Chichester.
31. Dickson, D. W. (1997) The pathogenesis of senile plaques, J. Neuropathol. Exp. Neurol. 56, 321-339.
32. Rufenacht, P., Guntert, A., Bohrmann, B., Ducret, A., and Dobeli, H. (2005) Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry, J. Mass Spectrom. 40, 193-201.
33. Liao, L., Cheng, D., Wang, J., Duong, D. M., Losik, T. G., Gearing, M., Rees, H. D., Lah, J. J., Levey, A. I., and Peng, J. (2004) Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection, J. Biol. Chem. 279, 37061-37068.
34. Lalowski, M., Golabek, A., Lemere, C. A., Selkoe, D. J., Wisniewski, H. M., Beavis, R. C., Frangione, B., and Wisniewski, T. (1996) The "nonamyloidogenic" p3 fragment (amyloid beta 17-42) is a major constituent of Down's syndrome cerebellar preamyloid, J. Biol. Chem. 271, 33623-33631.
35. He, W., and Barrow, C. J. (1999) The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta, Biochemistry 38, 10871-10877.
36. Delacourte, A., Sergeant, N., Champain, D., Wattez, A., Maurage, C. A., Lebert, F., Pasquier, F., and David, J. P. (2002) Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease, Neurology 59, 398-407.
37. Kalback, W., Watson, M. D., Kokjohn, T. A., Kuo, Y. M., Weiss, N., Luehrs, D. C., Lopez, J., Brune, D., Sisodia, S. S., Staufenbiel, M., Emmerling, M., and Roher, A. E. (2002) APP transgenic mice Tg2576 accumulate Aβ peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques, Biochemistry 41, 922-928.
38. Sergeant, N., Bombois, S., Ghestem, A., Drobecq, H., Kostanjevecki, V., Missiaen, C., Wattez, A., David, J. P., Vanmechelen, E., Sergheraert, C., and Delacourte, A. (2003) Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach, J. Neurochem. 85, 1581-1591.
39. Pype, S., Moechars, D., Dillen, L., and Mercken, M. (2003) Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein, J. Neurochem. 84, 602-609.
40. Kuo, Y. M., Kokjohn, T. A., Beach, T. G., Sue, L. I., Brune, D., Lopez, J. C., Kalback, W. M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., and Roher, A. E. (2001) Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains, J. Biol. Chem. 276, 12991-12998.
41. Liu, K., Doms, R. W., and Lee, V. M. (2002) Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression, Biochemistry 41, 3128-3136.
42. Holsinger, R. M., McLean, C. A., Beyreuther, K., Masters, C. L., and Evin, G. (2002) Increased β-Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects, Ann. Neurol. 57, 783-786.
43. Willem, M., Dewachter, I., Smyth, N., Van Dooren, T., Borghgraef, P., Haass, C., and Van Leuven, F. (2004) beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice. Am. J. Pathol. 165, 1621-1631.
44. Lee, E. B., Zhang, B., Liu, K., Greenbaum, E. A., Doms, R. W., Trojanowski, J. Q., and Lee, V. M. (2005) BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo, J. Cell Biol. 168, 291-302.
45. Kuo, Y. M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., and Roher, A. E. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains, J. Biol. Chem. 271, 4077-40781.
46. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nat. Med. 2, 864-870.
47. Amtul, Z., Lewis, P. A., Piper, S., Crook, R., Baker, M., Findlay, K., Singleton, A., Hogg, M., Younkin, L., Younkin, S. G., Hardy, J., Hutton, M., Boeve, B. F., Tang-Wai, D., and Golde, T. E. (2002) A presenilin 1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch, Neurobiol. Dis. 9, 269-273.
48. Roher, A. E., Kokjohn, T. A., Esh, C., Weiss, N., Childress, J., Kalback, W., Luehrs, D. C., Lopez, J., Brune, D., Kuo, Y. M., Farlow, M., Murrell, J., Vidal, R., and Ghetti, B. (2004) The human amyloid-beta precursor protein770 mutation V717F generates peptides longer than amyloid-beta-(40-42) and flocculent amyloid aggregates, J. Biol. Chem. 279, 5829-5836.